Facility Introduction
G2GBIO possesses its own GMP capable of producing clinical trial IP, which enables rapid conduction of clinical trials for various long-acting microsphere injectables
- Standards-Compliant Facility
- GMP-Compliant Facility
- Capable of manufacturing variouslong-acting microsphere injectables
- Using our proprietary InnoLAMP technology platform, our manufacturing facility is capable of producing long-acting microsphere injectables applying a variety of APIs.
- Ensuring quality uniformity through automated processes
- Minimizing human error and ensuring quality uniformity through the application of automated processes
- Production capability andquality system secured
- Production capability and quality system for early commercial production secured
GMP internal facility
